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Background: Originally described as a disorder of childhood, evidence now demonstrates the lifelong nature of
autism spectrum disorder (ASD). Despite the increase of the population over age 65, older adults with ASD remain
a scarcely explored subpopulation. This study set out to investigate the prevalence of clinically relevant behaviors
and medical problems in a sample of US adults aged 30 to 59 with ASD and intellectual disability (ID), in
comparison to those with ID only.
Methods: A cross-sectional study, with both an exploratory and replication analysis, was conducted using National
Core Indicators (NCI) multi-state surveys from 2009 to 2010 and 2010 to 2011. There were 4,989 and 4,261 adults
aged 30–59 with ID examined from the 2009 to 2010 and 2010 to 2011 samples, respectively. The two consecutive
annual samples consisted of 438 (9%) and 298 (7%) individuals with ASD and ID. Variables were chosen from the
NCI data as outcomes, including medication use for behavior problems, severe or aggressive behavior problems
and selected medical conditions.
Results: No age-associated disparities were observed between adults with ASD and ID versus adults with ID only in
either sample. For the 2009 to 2010 sample, the prevalence of support needed to manage self-injurious, disruptive
and destructive behavior in subjects with ASD and ID ranged from 40 to 60%. Similarly, the prevalence estimates of
self-injurious, disruptive and destructive behavior were each almost double in adults with ASD and ID relative to
those with ID only. These results were replicated in the 2010 to 2011 sample.
Conclusions: The findings of this study highlight the urgent need for research on the nature and treatment of
severe behavior problems in the rapidly increasing population of older adults with ASD. They also suggest the
importance of developing policies that expand our capacity to care for these individuals.
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Autism spectrum disorder (ASD) is a behavioral disorder
defined by the presence of social deficits and repetitive be-
haviors with onset in early childhood [1]. The prevalence
of ASD in children in the US, historically thought to be
rare, is now estimated at approximately one in eighty-
eight [2]. Initially described as a disorder of infancy [3],
more recent papers have begun to focus on young adults.
However, although reports now document that individuals
with ASD live into older age [4-6], almost no systematic* Correspondence: jpiven@med.unc.edu
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reproduction in any medium, provided the orstudies targeting individuals with ASD at older ages (that
is, over age 50 years) have been reported.
US Census Bureau estimates in 2006 projected a doub-
ling of the US population over 65 years of age by the
year 2030. Assuming the life expectancy of individuals
with ASD is similar to that of the general population,
based on current prevalence rates of ASD in school-age
children, this population expansion would result in ap-
proximately 700,000 individuals with ASD over 65 years
of age in less than 20 years. With the aging of the ASD
population in western countries, increasing rate of diag-
nosis of ASD and burgeoning use of services by persons
with ASD, the need to learn more about aging and aut-
ism is a high priority. Estimated per capita lifetime direct
and indirect costs of ASD in the US are over $3 million. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ASD living into their 60s and older [7]. The need to look
beyond younger affected populations in efforts to miti-
gate the burdens of ASD is highlighted by recent ana-
lyses noting that the largest contributor to the estimated
per capita lifetime direct cost of ASD is care during
adulthood [7]. A better understanding of the behavioral
progression, associated medical problems and care needs
of older adults with autism is critical for addressing this
approaching major public health problem. Additionally,
gaining knowledge of lifetime trajectories of ASD is
likely to provide important clues to teasing apart the
clinical and etiologic heterogeneity of this condition.
This knowledge will also provide needed information on
the trajectories of care from family to institutional care
patterns and needs as ASD patients move through their
lifecycle.
This study takes advantage of a large, nationwide
dataset that includes selected behavioral and medical
outcomes in adults of age 18 years and older, with clin-
ical diagnosis of both ASD and intellectual disability
(ID). The opportunity to examine older adults with both
ASD and ID afforded the chance to study those older
ASD individuals likely to have the greatest degree of
functional impairment. Estimates of the prevalence of ID
in individuals with ASD range from 38% in children with
ASD [2] to 70% in all those with ASD [8]. Contrasting
those individuals with both ASD and ID to those with
ID but not ASD allowed us to examine behavior-related,
neurological and sensory outcomes that were specific to
the aging ASD population.
Methods
Data source
The National Core Indicators (NCI) effort comprises col-
laboration between the National Association of State
Directors of Developmental Disability Services and the
Human Services Research Institute (HSRI) [9] to produce
a dataset that assesses performance in the delivery of state
services to adults with a developmental disability. The
core indicators include approximately 100 demographic
and outcome metrics, such as aspects of physical and
mental health, receipt of selected services and access to
care, thought to be important for measuring performance
of public agencies working in the area of developmental
disabilities. For the NCI effort, data are collected annually
on a random sample of approximately 400 adults ≥18
years of age (in each of the participating states/geographic
areas), who have an intellectual and/or developmental dis-
ability and have received at least one state service in
addition to case management during the fiscal year. NCI
workers acquire the data from sources of information
including medical and state records, as well as inter-
views with providers, family members and clients forthe Background Information Section (specified below).
Data are then compiled into a single dataset maintained
by the HSRI.
Data from the 2009 to 2010 and 2010 to 2011 multi-
state merged NCI surveys were obtained from the HSRI
after a detailed application process. To maximize confi-
dentiality, within the merged dataset for each year, there
is no variable to indicate the state of origin of the sub-
jects. In addition, subjects were de-identified and were
not assigned a unique identification number, thus mak-
ing it impossible to track whether subjects appeared
more than once within the two years of data obtained.
Conversations with HSRI officials suggested that mul-
tiple individual entries were less likely in more populated
states than in states with fewer subjects. Lacking cer-
tainty about the possibility of minimal duplication of in-
dividuals, it was decided that the data should not be
merged across the multi-year sampling frame but rather
investigated one year at a time. A cross-sectional method
was therefore employed using the 2009 to 2010 data to
conduct an exploratory analysis and subsequent 2010 to
2011 data to provide a replication sample.
Although 24 states currently participate in the NCI ef-
fort, data for the exploratory study were from 11,599
subjects from the 18 regions that administered the Adult
Consumer Survey in 2009 to 2010: Alabama, Arkansas,
Washington, DC, Georgia, Illinois, Kentucky, Louisiana,
Maine, Missouri, North Carolina, New Jersey, New York,
Ohio, Oklahoma, Pennsylvania, Texas, Wyoming and
Orange County, California. Data for the replication study
were from 8,796 individuals from the 15 geographic
areas that administered the Adult Consumer Survey
in 2010 to 2011: Alabama, Arkansas, Florida, Georgia,
Illinois, Kentucky, Louisiana, Maine, Missouri, North
Carolina, New Hampshire, New York, Ohio, Oklahoma
and Pennsylvania. State sampling strategies for the 2009
to 2010 and 2010 to 2011 samples appear in Appendix B
of the 2009 to 2010 and 2010 to 2011 Consumer Outcomes
Final Report [10,11], respectively.
National core indicators
The Background Information Section of the NCI Con-
sumer Survey served as the source of all variables used
in this study. This section consisted of measures such as
the service user's demographics, functioning, clinical
diagnoses, general health, problem behaviors, living ar-
rangements and services. These variables, including
diagnosis of ASD, were almost always obtained from
agency records or information systems, and only occa-
sionally by case managers or surveyors who interviewed
the service user and/or an informant. Each state consid-
ered a diagnosis of ASD as any of the conditions listed
as pervasive developmental disorders in the Diagnostic
and Statistical Manual of Mental Disorders (4th ed.;
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including medical record entries (for example, autism,
Asperger’s disorder or pervasive developmental disorder).
The emphasis of the current study was on medical and
behavioral outcomes. Within this domain, variables were
selected for inclusion in this study based on decisions
made by the research team on the face validity of the in-
formation obtained. Variables that may be of potential
interest, ‘medication for mood disorders?’, ‘medication
for anxiety?’ and ‘medication for psychotic disorders?’,
were not deemed of sufficient validity for inclusion be-
cause specific definitions (for example, the list of anxiety
medications) were not provided for such determinations.
After detailed examination, the following variables, as
they appear in the NCI data, were chosen as outcomes
in this study: (1) ‘medication for behavior problems?’, (2)
‘limited or no vision-legally blind’, (3) ‘hearing loss-
severe or profound’, (4) ‘physical disability’, (5) ‘seizure
disorder or neurological problem’, (6) ‘Alzheimer’s dis-
ease or other dementia’, (7) ‘does this person need sup-
port to manage self-injury behavior?’, (8) ‘does this
person need support to manage disruptive behavior?’
and (9) ‘does this person need support to manage de-
structive behavior?’ For outcomes (2) to (6) a clinical
diagnosis of the condition was inferred to have been
retrieved from the subject’s medical history or record.
Responses to these variables appeared as ‘yes’, ‘no’,
‘don’t know’ or ‘unknown’, except for those requiring an
assessment of the level of support needed to manage
self-injurious, disruptive or destructive behavior. These
latter responses were characterized as: ‘extensive support
needed’, ‘some support needed’, ‘no support needed’ or
‘don’t know’. Due to a small proportion (<10%) of sub-
jects in this sample for whom ‘extensive support needed’
was indicated, the responses ‘extensive support needed’
and ‘some support needed’ were combined into one cat-
egory as the ‘yes’ response. Accordingly, ‘no support
needed’ served as the ‘no’ response. For all variables in-
cluded in this study, any entries of ‘don’t know’ or ‘un-
known’ were treated as missing.
Sample
The multi-state NCI sample from each year was largely
limited to individuals diagnosed with mental retardation,
referred to here as ID. In the 2009 to 2010 dataset, for
instance, of the 10,935 subjects with relevant diagnostic
information available, 10,627 (97.2%) had a diagnosis of
ID. The present study was limited to those individuals
with ID, with or without a concurrent ASD diagnosis.
Diagnoses of both ID and ASD were reported in sub-
jects’ case records and presumably established by a
qualified clinician in the community beforehand. Indi-
viduals with ID and ASD (referred to in this study as the
ASD group) served as the exposed group; those with IDwithout ASD (referred to as the ID-only group) served as
the comparison group. The dataset also included levels of
ID (mild, moderate, severe, profound or unspecified). Indi-
viduals with profound or unspecified levels of ID were ex-
cluded from this study. The exclusion of individuals with
profound ID was based on the complexities introduced in
the diagnosis of ASD in individuals with such a severe de-
gree of intellectual impairment, raising questions about the
validity of ASD diagnosis in these individuals. This study
was exempt from Institutional Review Board approval.
The primary focus of this study was on medical/behav-
ioral problems in older adults with ASD. Given the lim-
ited number of subjects in the database with ASD who
were at least 60 years of age, the target population of the
study was limited to adults 50 to 59 years of age. To
provide insight into potential age effects that might dif-
fer in this age group relative to younger adults with ASD
and ID, additional age groups of individuals 30 to 39 and
40 to 49 years of age were included.
Statistical analyses
To model the association between autism/ASD and each of
the selected outcomes, a separate Poisson regression model
with a robust error variance/sandwich term [13] was devel-
oped. The use of Poisson regression with a sandwich error
term, which produces prevalence ratios (PRs), is a widely
preferred statistical method to estimate measures of effect
when using cross-sectional data for outcomes of higher
prevalence [14-17]. This form of Poisson regression pro-
vides similar measure-of-effect estimates to other modeling
techniques for rare outcomes [14] and so was also used for
the lower-prevalence outcomes in this study. Since age
group, gender and level of ID may potentially confound the
relationship between ASD and all outcomes selected for
this study [2,5,18], these covariates were controlled for
within the modified Poisson regression model for each
outcome of interest. Adjusting for these potential con-
founders, prevalence ratios between the ASD and ID-
only groups on each selected outcome were deemed sig-
nificant at a two-tailed value of α = 0.05. Age group,
gender and level of ID interaction terms were also
tested for significance in each model at a conservative
two-tailed value of α = 0.10, given the relatively smaller
sample sizes in several of the subgroups stratified by age
and level of ID.
Poisson regression models with robust error-variance
were additionally utilized to examine whether these cova-
riates were associated with each of the selected outcomes
differently across the ASD and ID-only diagnostic groups.
The data for this paper were generated using SAS software,
Version 9.3 of the SAS system for Windows. Copyright ©
2011 SAS Institute Inc. SAS; all other SAS Institute Inc.
product or service names are registered trademarks or
trademarks of SAS Institute Inc., Cary, NC, USA).
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Exploratory sample (2009 to 2010)
Participants
The 2009 to 2010 cross-sectional sample of 4,989 adults
aged 30 to 59 years with mild, moderate or severe ID
consisted of 438 (9%) individuals in the ASD group and
4,551 (91%) adults in the ID-only group (Table 1). In
total, there were 1,516 (30%) individuals of 30 to 39
years of age, 1,808 (36%) of 40 to 49 years of age and
1,665 (33%) of 50 to 59 years of age. Mean age was 42
(SD 8) years and 45 (SD 8) years for those in the ASD
group and ID-only group, respectively. Approximately
75% of the ASD group and just over half of the ID-only
group were male. Severity of ID varied from 27% with
mild and 37% with moderate ID to 36% with severe ID
in the ASD group; and, 47% with mild and 33% with
moderate ID to 19% with severe ID in the ID-only
group. The majority of adults in the ASD group
(75%) and ID-only group (72%) were classified as white,
non-Hispanic.
Outcomes
Nearly 50% of subjects in the ASD group and 25% of
those in the ID-only group were prescribed medications
for behavioral problems (Table 2). There were substan-
tially higher percentages of subjects in the ASD group
needing support for behavioral problems compared to
the ID-only group across all three types of problem be-
haviors examined, with proportions in individuals with
ASD and ID that were generally two to three times those
reported in individuals with ID only. Four percent of the
ASD group and 6% of the ID-only group were reported
as limited or no vision-legally blind, and a limited num-
ber of individuals in both groups were also reported as
having hearing loss-severe or profound. Slightly less than
5% of individuals in the ASD group and about 10% of
members of the ID-only group were reported to have a
physical disability. The presence of a seizure disorder or
neurological problem was reported in approximately
20% of the ASD group compared to 25% of the ID-only
group. Finally, Alzheimer’s disease or other dementia
was noted in 2% of the ASD group and 1% of the
ID-only group.
No interaction terms related to age group, gender or
level of ID were significant additions to the model for any
outcome (P >0.10), indicating that the effect of a diagnosis
of ASD on the prevalence estimates of the outcomes of
interest was not specific to any age group, gender or level
of ID. Therefore, a separate Poisson regression model with
a sandwich error term was developed for the analysis of
each selected outcome across the entire sample of in-
dividuals aged 30 to 59 years. Prevalence ratios, adjusted
for age group, gender and level of ID, with 95% CIs, are
reported in Table 3.Prevalence estimates for the categories, medication for
behavior problems (PR 1.11, 95% CI 1.07, 1.15); does this
person need support to manage self-injury behavior? (PR
1.87, 95% CI 1.62, 2.17); does this person need support to
manage disruptive behavior? (PR 1.25, 95% CI 1.12, 1.39);
and does this person need support to manage destructive
behavior? (PR 1.38, 95% CI 1.19, 1.59), were all signifi-
cantly higher in the ASD group relative to the ID-only
group. Notably, the ASD group had almost twice the
prevalence for the category, does this person need support
to manage self-injury behavior?, compared to the ID-only
group. The prevalence of physical disability (PR 0.95, 95%
CI 0.93, 0.97) and seizure disorder or neurological prob-
lem (PR 0.93, 95% CI 0.90, 0.96) was significantly lower in
the ASD group relative to the ID-only group. There were
no significant differences between the two groups for the
categories, limited or no vision-legally blind (PR 0.98, 95%
CI 0.96, 1.00); hearing loss-severe or profound (PR 0.99,
95% CI 0.97, 1.01); or Alzheimer’s disease or other demen-
tia (PR 1.01, 95% CI 1.00, 1.03).
More severe level of ID was significantly associated with
medication for behavior problems?; does this person need
support to manage self-injury behavior?; and seizure dis-
order or neurological problem, in both the ASD group
and ID-only group. A significant relationship between age
group and hearing loss-severe or profound was observed
within both groups as well, with slightly elevated preva-
lence estimates of hearing problems reported with increas-
ing age. Furthermore, increasing severity of ID was
significantly associated with the categories, does this per-
son need support to manage disruptive behavior?; does
this person need support to manage destructive behavior?;
limited or no vision-legally blind; and physical disability,
within the ID-only group but not the ASD group. None of
the covariates in this study (age group, gender or level of
ID) were associated with Alzheimer’s disease or other de-
mentia in either the ASD or ID-only group. Gender was
not associated with any outcomes in either group. All
other possible associations between any of the outcomes
and covariates, whether bivariate or multivariate, were
non-significant (P >0.05).
Replication sample (2010 to 2011)
Participants
To reflect whether the results from the 2009 to 2010 sam-
ple could be replicated, the 2010 to 2011 cross-sectional
sample of 4,261 adults aged 30 to 59 years, with mild,
moderate or severe ID was examined (Table 4). This sam-
ple was made up of 298 (7%) individuals in the ASD group
and 3,963 (93%) adults in the ID-only group, consisting of
1,439 (34%) subjects 30 to 39 years of age, 1,573 (37%) 40
to 49 years of age and 1,249 (29%) 50 to 59 years of age.
Members of the ASD group were of mean age 41 (SD 8)
years, and the mean age of those in the ID-only group was
Table 1 Demographic variables among the ASD group and the ID-only group in the 2009 to 2010 NCI sample of adults
aged 30-59 years
Demographic variables ASD groupa ID-only groupb
(n = 438), number (%) (n = 4,551), number (%)
Age
30 to 39 years 190 (43) 1,326 (29)
40 to 49 years 154 (35) 1,654 (36)
50 to 59 years 94 (21) 1,571 (35)
Missing data 0 0
Gender
Female 117 (27) 2,008 (44)
Male 319 (73) 2,532 (56)
Missing data 2 11
Race/ethnicity
White, non-hispanic 326 (75) 3,280 (72)
Black, non-hispanic 84 (19) 914 (20)
Hispanic 14 (3) 228 (5)
Asian 4 (1) 48 (1)
American Indian 2 (0) 44 (1)
Other 3 (1) 15 (0)
Missing data 5 19
Marital status
Single, never married 431 (100) 4,257 (95)
Single, married in the past 0 (0) 142 (3)
Married 1 (0) 111 (2)
Missing data 6 41
Level of ID
Mild 107 (27) 2,055 (47)
Moderate 147 (37) 1,441 (33)
Severe 146 (37) 840 (19)
Missing data 38 215
Primary language
English 433 (99) 4,440 (98)
Other 5 (1) 95 (2)
Missing data 0 16
Primary means of expression
Spoken 280 (64) 3,933 (87)
Gesture/body language 137 (31) 477 (11)
Sign language/finger spelling 13 (3) 61 (1)
Communication aid/device 3 (1) 21 (0)
Other 3 (1) 33 (1)
Missing data 2 26
aASD group: diagnosis of intellectual disability (ID) and autism spectrum disorder (ASD); bID-only group: diagnosis of ID but no diagnosis of ASD. NCI, National
Core Indicators.
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Table 2 Outcomes among the ASD group and ID-only group in the 2009 to 2010 NCI sample of adults aged
30-59 years
Outcomes ASD groupa ID-only groupb
(n = 438), number (%) (n = 4,551), number (%)
Medication for behavior problems?
Yes 174 (42) 1,075 (25)
No 240 (58) 3,179 (75)
Missing data 24 297
Limited or no vision-legally blind
Yes 19 (4) 259 (6)
No 419 (96) 4,292 (94)
Missing data 0 0
Severe or profound hearing loss
Yes 16 (4) 217 (5)
No 422 (96) 4,334 (95)
Missing data 0 0
Physical disability
Yes 19 (4) 448 (10)
No 419 (96) 4,103 (90)
Missing data 0 0
Seizure disorder or neurological problem
Yes 91 (21) 1,227 (27)
No 347 (79) 3,324 (73)
Missing data 0 0
Alzheimer's disease or other dementia
Yes 9 (2) 56 (1)
No 429 (98) 4,495 (99)
Missing data 0 0
Does this person need support to manage self-injury behavior?
Extensive 46 (11) 174 (4)
Some 120 (28) 605 (14)
None 262 (61) 3,647 (82)
Missing data 10 125
Does this person need support to manage disruptive behavior?
Extensive 52 (12) 372 (8)
Some 164 (38) 1,374 (31)
None 214 (50) 2,696 (61)
Missing data 8 109
Does this person need support to manage destructive behavior?
Extensive 44 (10) 202 (5)
Some 114 (27) 821 (19)
None 270 (63) 3,404 (77)
Missing data 10 124
aASD group: diagnosis of intellectual disability (ID) and autism spectrum disorder (ASD); bID-only group: diagnosis of ID but no diagnosis of ASD. NCI, National
Core Indicators.
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Table 3 Prevalence ratios (ASD group versus ID-only
group) for 2009 to 2010 NCI sample of adults aged
30-59 years
Outcomes Prevalence ratio (95% CI)
Medication for behavior problems 1.11 (1.07, 1.15)
Limited or no vision-legally blind 0.98 (0.96, 1.00)
Severe or profound hearing loss 0.99 (0.97, 1.01)
Physical disability 0.95 (0.93, 0.97)
Seizure disorder or neurological problem 0.93 (0.90, 0.96)
Alzheimer's disease or other dementia 1.01 (1.00, 1.03)
Does this person need support to manage
self-injury behavior?
1.87 (1.62, 2.17)
Does this person need support to manage
disruptive behavior?
1.25 (1.12, 1.39)
Does this person need support to manage
destructive behavior?
1.38 (1.19, 1.59)
Prevalence ratios were adjusted for age group (30 to 39, 40 to 49, 50 to 59
years), gender and level of intellectual disability (ID). ASD group: diagnosis of
ID and autism spectrum disorder (ASD); ID-only group: diagnosis of ID but no
diagnosis of ASD. NCI, National Core Indicators.
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group and just over half of those in the ID-only group were
male. In the ASD group, 31, 34 and 36% of subjects were
noted to have mild, moderate or severe ID, respectively,
whereas in the ID-only group, 47%, 35% and 18% of adults
had mild, moderate or severe ID, respectively. Most adults
in the ASD group (75%) and ID-only group (76%) were
white, non-Hispanic.
Outcomes
As in the analysis of the exploratory sample, interaction
terms related to age group, gender or level of ID did
not provide significant additions to the model for any
of the selected outcomes examined (P >0.10) for the
replication sample. The frequencies of the outcomes
across the ASD group and ID-only group also were very
similar in the replication sample to those in the ex-
ploratory sample. For more detailed figures, please
refer to Table 5. PRs, adjusted for possible confounding
by age group, gender and level of ID, as well as 95%
CIs, are reported in Table 6.
Similar to the exploratory sample, more severe level
of ID was significantly associated with disruptive be-
havior, destructive behavior, limited or no vision and
physical disability within the ID-only group but not the
ASD group for the replication sample. However, while
increasing severity of ID was significantly associated
with medication for behavior problems, self-injury be-
havior and seizure disorder or neurological problem
within both diagnostic groups for the exploratory sam-
ple, these associations were not significant in the ASD
group for the replication sample.Discussion
This large-scale, systematic study was designed to examine
clinical problems specific to older adults with ASD and
ID. Adults with both ASD and ID constitute those individ-
uals with ASD likely to have the greatest degree of behav-
ioral and associated medical problems [19], and therefore
are likely to provide insights into those affected adults re-
quiring the greatest levels of care. Context with respect to
age-related changes was also provided by contrasting the
50- to 59-year-old age group against subjects aged 30 to
39 and 40 to 49 years. The large size of the overall sample
and the ability to examine the same variables using sam-
ples from two consecutive years increased confidence in
the validity of the presented findings.
No age-associated differences were detected in any of
the selected variables between the ASD group and ID-
only group across the 10-year age intervals. Similarly, of
all the outcomes, age was associated only with hearing
loss. Given that the NCI data did not include a sufficient
number of subjects aged 60 years and over, the lack of
differences in outcomes analyzed by age group may have
stemmed from not being able to examine differences in
conditions that usually present themselves after age 59
years, when many chronic diseases have their greatest
impact. Thus, it simply may be the case that the individ-
uals analyzed in this study were at too premature of a
stage in life for the degenerative complications of aging
to have occurred.
The most striking result of this study was the high
prevalence of severe behavioral problems in subjects
with ASD and ID relative to those with ID only. For ex-
ample, the use of medications for behavioral problems
was noted in over 40% of the ASD group in both the ex-
ploratory and replication samples. The prevalence of
support needed for severe behavioral problems in the
ASD group ranged from 37% (for destructive behavior in
the exploratory sample) to 60% (for disruptive behavior
in the replication sample). In general, severe behavioral
disturbances were reported approximately twice as much
in the ASD group as in the ID-only group. Although no
age-associated changes were revealed, the frequency of
problem behaviors requiring intervention in the ASD
group was sufficient to raise concern.
The primary conclusion reached in this study, namely,
that severe behavioral problems are the consequences of
autism, differs from the recent findings of Totsika et al.
[20]. In that study, older adults with ASD and ID
reported a significantly more severe level of behavioral
problems than a comparison group of adults with ID
only. However, this difference was no longer present
after matching for adaptive behavior, leading the authors
to conclude that impairment in adaptive skills in older
adults with ASD and ID, somehow viewed as independ-
ent of the defining features of ASD, was responsible for
Table 4 Demographic variables among the ASD group and ID-only group in the 2010 to 2011 NCI sample of adults
aged 30-59 years
Demographic variables ASD groupa ID-only groupb
(n = 298), number (%) (n = 3,963), number (%)
Age
30 to 39 years 148 (50) 1,291 (33)
40 to 49 years 100 (34) 1,473 (37)
50 to 59 years 50 (17) 1,199 (30)
Missing data 0 0
Gender
Female 74 (25) 1,825 (46)
Male 224 (75) 2,137 (54)
Missing data 0 1
Race/ethnicity
White, non-hispanic 224 (75) 3,009 (77)
Black, non-hispanic 51 (17) 738 (19)
Hispanic 14 (5) 128 (3)
Asian 4 (1) 20 (1)
American Indian 1 (0) 32 (1)
Other 3 (1) 17 (0)
Missing data 1 19
Marital Status
Single, never married 296 (99) 3,711 (94)
Single, married in the past 2 (1) 131 (3)
Married 0 (0) 97 (2)
Missing data 0 24
Level of ID
Mild 76 (31) 1,692 (47)
Moderate 85 (34) 1,266 (35)
Severe 87 (35) 637 (18)
Missing data 50 368
Primary language
English 282 (96) 3,880 (98)
Other 12 (4) 67 (2)
Missing data 4 16
Primary means of expression
Spoken 161 (55) 3,387 (86)
Gesture/body language 107 (36) 443 (11)
Sign language/finger spelling 18 (6) 62 (2)
Communication aid/device 3 (1) 21 (1)
Other 6 (2) 22 (1)
Missing data 3 28
aASD group: diagnosis of intellectual disability (ID) and autism spectrum disorder (ASD); bID-only group: diagnosis of ID but no diagnosis of ASD. NCI, National
Core Indicators.
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Table 5 Outcomes among ASD group and ID-only group in the 2010 to 2011 NCI sample of adults aged 30-59 years
Outcomes ASD groupa ID-only group b
(n = 298), number (%) (n = 3,963), number (%)
Medication for behavior problems?
Yes 124 (44) 847 (22)
No 160 (56) 2,919 (78)
Missing data 14 197
Limited or no vision-legally blind
Yes 13 (4) 208 (5)
No 285 (96) 3,755 (95)
Missing data 0 0
Severe or profound hearing loss
Yes 13 (4) 192 (5)
No 285 (96) 3,771 (95)
Missing data 0 0
Physical disability
Yes 4 (1) 319 (8)
No 279 (99) 3,594 (92)
Missing data 15 50
Seizure disorder or neurological problem
Yes 52 (17) 838 (21)
No 246 (83) 3,125 (79)
Missing data 0 0
Alzheimer's disease or other dementia
Yes 1 (0) 51 (1)
No 297 (100) 3,912 (99)
Missing data 0 0
Does this person need support to manage self-injury behavior?
Extensive 34 (12) 145 (4)
Some 82 (28) 544 (14)
None 173 (60) 3,182 (82)
Missing data 9 92
Does this person need support to manage disruptive behavior?
Extensive 45 (15) 294 (8)
Some 132 (45) 1,077 (28)
None 115 (40) 2,499 (65)
Missing data 6 93
Does this person need support to manage destructive behavior?
Extensive 40 (14) 209 (5)
Some 82 (28) 643 (17)
None 167 (58) 3,013 (78)
Missing data 9 98
aASD group: diagnosis of intellectual disability (ID) and autism spectrum disorder (ASD); b ID-only group: diagnosis of ID but no diagnosis of ASD.
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in adults with ASD and ID relative to those with ID
only. We view the lack of a significant difference in theseverity of behavior problems between the groups as a
result of over-matching, as adaptive behavior deficits are
likely to be integrally related to the defining features of
Table 6 Prevalence ratios (ASD group versus ID-only
group) for the 2010 to 2011 NCI sample of adults aged
30-59 years
Outcomes Prevalence ratio (95% CI)
Medication for behavior problems? 1.15 (1.09, 1.20)
Limited or no vision-legally blind 0.98 (0.96, 1.00)
Severe or profound hearing loss 1.00 (0.98, 1.03)
Physical disability 0.93 (0.92, 0.95)
Seizure disorder or neurological problem 0.95 (0.91, 0.99)
Alzheimer's disease or other dementia 0.99 (0.99, 1.00)
Does this person need support to manage
self-injury behavior?
1.89 (1.58, 2.26)
Does this person need support to manage
disruptive behavior?
1.62 (1.44, 1.81)
Does this person need support to manage
destructive behavior?
1.61 (1.36, 1.90)
Prevalence ratios were adjusted for age group (30 to 39, 40 to 49, 50 to 59
years), gender and level of intellectual disability (ID). ASD group: diagnosis of
ID and autism spectrum disorder (ASD); ID-only group: diagnosis of ID but no
diagnosis of ASD. NCI, National Core Indicators.
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separated from the condition itself. Similar results ap-
pear in a separate study by Melville et al. [21], which
compared 77 subjects (aged 16 to 84 years) with ASD
and ID to 154 individuals with ID only. Although a sig-
nificant increase in the point prevalence of problem be-
haviors among those with ASD and ID relative to those
with ID only was initially noted, no significant difference
in this outcome was reported after a 1:2 matching
procedure (due to the relatively small size of the group
of individuals with ASD and ID) between the groups on
age, gender, intellectual ability and co-morbid Down
syndrome. Once again, the vanishing of this significant
difference may be attributed to problems in the matching
methods. Consistent with the reported findings of the
present study, a more recent study comparing 124
adults (aged 18 to 65 years) with ASD and ID to 562
adults with ID only [22], reported an almost four-fold
increase in the presence of challenging behavior among
those with ASD and ID.
Differences in the methods and ascertainment
schemes used in these studies make them difficult to
compare. Yet, whereas previous studies have combined
subjects across wider age ranges, the present study uti-
lized a considerably larger sample and focused on a
more narrowly defined age range (that is, 30 to 59
years). Such inconsistency across the literature ultim-
ately points to the need for prospective studies of the
population of uniformly diagnosed, older adults with
ASD after systematic ascertainment from sources un-
biased with respect to the outcomes being studied.
The high proportions of adults in both diagnostic groups
who had behavioral problems noted in this study areconsistent with the reports of associated (non-diagnostic)
behaviors and co-morbid psychiatric conditions in children,
adolescents and young adults with ASD and/or ID [23-29].
One possible interpretation for the increased frequencies of
behavioral problems reported in the ASD group relative to
the ID-only group is that having problems in behavior may
be a direct expression of the biological substrate of autism.
Indication of such a possibility is provided through the ob-
servation of significant associations between level of ID and
disruptive and destructive behaviors within the ID-only
group but not the ASD group in both the exploratory and
replication samples. Whereas intellectual deficits seem to
account for the presentation of behavior problems in the
ID-only group, the lack of a significant relationship between
level of ID and these types of behaviors in the ASD group
suggests that some inherent feature of the actual ASD con-
dition may be responsible for the alarmingly high presenta-
tions of behavior problems in adults aged 30 to 59 years
with ASD and ID.
An alternative or additional explanation is that the re-
lationship between ASD and associated behavioral prob-
lems is indirectly mediated by autistic symptoms or
abilities. For instance, social isolation/social deficits may
increase the risk for psychiatric or behavioral problems
over time. Additionally, caregivers of adults with ASD
may not be sufficiently skilled in the care of older indi-
viduals with ASD, indirectly contributing to increased
rates of behavioral problems. Longitudinal trajectories
and the complex interplay of direct and indirect effects
on associated behavioral outcomes in autism are areas
that have received little attention in the research litera-
ture. Investigation into potential mechanisms underlying
the high prevalence of behavioral problems in this study
is warranted on the basis of the present results.
Given the rapidly expanding population of older adults
in western societies, these data raise major public-health
concerns about our ability to care for the aging popula-
tion of adults with ASD and ID. The findings of this
study suggest a critical need for research into the assess-
ment and treatment of severe behavioral problems asso-
ciated with ASD appearing around midlife, along with
efforts for training of the workforce in appropriate treat-
ment of this expanding population. These findings fur-
ther suggest that there will be substantial demands on
systems of care required to manage the problems faced
by these individuals, their families and communities as
they enter residential and nursing care facilities for older
adults. The development of health care policies that ad-
dress family support, institutional care and financing of
care for older adults with ASD is, therefore, of critical
importance in planning for the care of the aging popula-
tion of individuals with ASD.
Two outcomes, namely, physical disability and seiz-
ure disorder or neurological problem, were slightly less
Kats et al. Journal of Neurodevelopmental Disorders 2013, 5:27 Page 11 of 12
http://www.jneurodevdisorders.com/content/5/1/27prevalent in the ASD group relative to the ID-only
group. No differences were reported in the prevalence
estimates for vision or hearing deficits between the
groups either. As expected on the basis of findings in
the general population, a higher prevalence of hearing
impairment was associated with increasing age in both
groups, lending support to the validity of this rating.
Similarly, no relative differences were observed for the
prevalence of Alzheimer’s disease or other dementia.
However, early-onset Alzheimer’s disease (before age
60 years) represents less than 5% of all those who are
eventually diagnosed with Alzheimer’s disease [30],
suggesting that the individuals analyzed in this study
may have been too young to adequately examine this
relationship.
Strengths and limitations
Several significant limitations of this study should be
noted. The NCI database, spread across many states in
the US, does not include unique subject identifiers, mak-
ing it impossible to examine overlap in annual samples
or across states. From discussions with NCI administra-
tors and trainers, although there is an attempt to avoid
such redundancy in the sampling for some states, the
existence of this problem ultimately cannot be ignored.
Another limitation concerns the quality of several of the
questions that appear in the NCI data, such as those
pertinent to medications that may be associated with
particular psychiatric conditions. Standardization across
states and raters was not as rigorous as typically seen in
studies where data collection was controlled by the in-
vestigators, and so these measures were excluded from
analyses.
Furthermore, it is important to note that ASD is likely
to be under-diagnosed in older populations [31,32],
which may have resulted in the inclusion of adults with
ASD in the ID-only groups of this study. Overall, the
validity of the diagnostic classification, as provided in
this administrative dataset, is another limitation of this
study. However, the availability of such a large and geo-
graphically wide-ranging sampling frame, even given the
above noted limitation, strengthened the validity and
generalizability of the findings reported here.
Summary and future directions
Markedly high prevalence estimates of severe behavioral
problems in adults with ASD and ID between 30 and 59
years of age are reported in this study. These results
have great relevance to policy makers. There is currently
no scientific knowledge about mechanisms underlying
the behavioral problems noted in this age group and
limited knowledge regarding treatment. As seen in the
emergence of the specialty fields of geriatric medicine
and geriatric psychiatry, the need for the advancementof specific expertise in the care of older individuals with
ASD is underscored by the especially high proportions
of significant clinical symptoms reported in the ASD
group. As knowledge emerges about appropriate strat-
egies for assessment and treatment of the aging popula-
tion of individuals with ASD, expanded training efforts
to build treatment capacity in the community will be es-
sential. Research to identify the most effective interven-
tion and prevention strategies will be required. New
approaches to case finding and diagnosis of this age
group (where a lack of childhood informants compli-
cates our current diagnostic schemes) will contribute
importantly to our ability to provide effective prevention
and intervention.Conclusions
In summary, a multitude of factors, including the roles
for changing social networks and available community
support, changes in underlying neurobiology with age
and the cumulative effects of life-long symptoms, may
all affect later-age outcomes of ASD. Given the likely
enormity of the problem and resultant associated costs
of managing health concerns in this population of aging
adults with ASD, these data highlight the urgency for
further research in this area.
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